GERN Insider Transactions
125 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.
GERN insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | 2026-02-18 | Sale | 9,855.0 | $1.94 |
| LAWLIS V BRYAN | Director | 2025-05-09 | Purchase | 13,300.0 | $1.18 |
| Samuels Scott Alan | EVP, Chief Legal Officer | 2025-02-27 | Purchase | 15,000.0 | $1.61 |
| SCARLETT JOHN A | Chairman, President and CEO | 2025-02-27 | Purchase | 12,500.0 | $1.77 |
| Ziegler James | EVP, Chief Commercial Officer | 2025-02-27 | Purchase | 100,000.0 | $1.6 |
| GRETHLEIN ANDREW J | EVP, Chief Operating Officer | 2024-07-08 | Sale | 674,348.0 | $4.56 |
| Feller Faye | EVP, Chief Medical Officer | 2024-06-10 | Sale | 287,900.0 | $4.63 |
| Kapur Anil | EVP, Corp Strategy & CCO | 2024-06-10 | Sale | 421,875.0 | $4.65 |
| SCARLETT JOHN A | Chairman, President and CEO | 2024-06-04 | Sale | 600,000.0 | $4.0 |
| LAWLIS V BRYAN | Director | 2024-05-15 | Sale | 35,000.0 | $3.75 |
| O'Farrell Elizabeth G. | Director | 2023-08-24 | Purchase | 6,579.0 | $2.28 |
| O'Farrell Elizabeth G. | Director | 2023-08-24 | Purchase | 6,607.0 | $2.28 |
| LAWLIS V BRYAN | Director | 2023-05-11 | Sale | 35,000.0 | $3.0 |
| Molineaux Susan | Director | 2023-05-01 | Sale | 35,000.0 | $2.48 |
| SCARLETT JOHN A | Chairman, President and CEO | 2023-02-10 | Sale | 446,668.0 | $3.0 |
| GRETHLEIN ANDREW J | EVP, Chief Operating Officer | 2023-02-09 | Sale | 234,719.0 | $3.03 |
| GRETHLEIN ANDREW J | EVP, Chief Operating Officer | 2023-02-09 | Sale | 150,000.0 | $3.03 |
| SCARLETT JOHN A | Chairman, President and CEO | 2023-02-09 | Sale | 446,666.0 | $3.03 |
| Bloom Olivia Kyusuk | EVP, Chief Financial Officer | 2023-02-08 | Sale | 400,000.0 | $3.08 |
| SCARLETT JOHN A | Chairman, President and CEO | 2023-02-08 | Sale | 446,666.0 | $3.08 |
| O'Farrell Elizabeth G. | Director | 2020-08-21 | Purchase | 17,441.0 | $1.73 |
| O'Farrell Elizabeth G. | Director | 2020-01-10 | Purchase | 2,200.0 | $1.34 |
| O'Farrell Elizabeth G. | Director | 2020-01-10 | Purchase | 800.0 | $1.35 |
| BEHRS MELISSA KELLY | EVP, Chief Business Officer | 2019-04-09 | Sale | 120,635.0 | $2.0 |
| Spiegel Robert J. | Director | 2018-09-13 | Sale | 35,000.0 | $6.85 |
| Spiegel Robert J. | Director | 2018-09-13 | Sale | 35,000.0 | $6.85 |
| Spiegel Robert J. | Director | 2018-09-13 | Sale | 35,000.0 | $6.85 |
| Spiegel Robert J. | Director | 2018-09-13 | Sale | 15,000.0 | $6.85 |
| Spiegel Robert J. | Director | 2018-09-13 | Sale | 10,000.0 | $6.85 |
| Spiegel Robert J. | Director | 2018-09-13 | Sale | 45,000.0 | $6.85 |
| ROSENFIELD STEPHEN | EVP, Genl Counsel & Secretary | 2018-08-24 | Sale | 37,500.0 | $4.51 |
| ROSENFIELD STEPHEN | EVP, Genl Counsel & Secretary | 2018-08-24 | Sale | 112,500.0 | $4.51 |
| ROSENFIELD STEPHEN | EVP, Genl Counsel & Secretary | 2018-08-24 | Sale | 131,250.0 | $4.51 |
| ROSENFIELD STEPHEN | EVP, Genl Counsel & Secretary | 2018-08-24 | Sale | 420,000.0 | $4.51 |
| ROSENFIELD STEPHEN | EVP, Genl Counsel & Secretary | 2018-08-24 | Sale | 200,000.0 | $4.51 |
| ROSENFIELD STEPHEN | EVP, Genl Counsel & Secretary | 2018-08-24 | Sale | 425,000.0 | $4.51 |
| ROSENFIELD STEPHEN | EVP, Genl Counsel & Secretary | 2018-08-24 | Sale | 36,000.0 | $4.51 |
| Bloom Olivia Kyusuk | EVP, Chief Financial Officer | 2015-05-29 | Sale | 2,380.0 | $3.84 |
| BEHRS MELISSA KELLY | EVP BD and Port&Alliance Mgmt | 2015-05-29 | Sale | 2,380.0 | $3.84 |
| Hofstaetter Thomas | Director | 2015-03-18 | Sale | 70,000.0 | $4.1 |
| Bloom Olivia Kyusuk | EVP, Chief Financial Officer | 2014-05-29 | Sale | 3,379.0 | $2.1 |
| BEHRS MELISSA KELLY | EVP Portfolio & Alliance Mgmt | 2014-05-29 | Sale | 4,826.0 | $2.1 |
| BRADBURY DANIEL | Director | 2014-05-09 | Purchase | 142,776.0 | $1.75 |
| Bloom Olivia Kyusuk | EVP, Chief Financial Officer | 2014-04-01 | Sale | 7,435.0 | $2.13 |
| BEHRS MELISSA KELLY | EVP Portfolio & Alliance Mgmt | 2014-04-01 | Sale | 12,310.0 | $2.13 |
| SCARLETT JOHN A | President and CEO | 2013-04-01 | Purchase | 50,000.0 | $1.03 |
| BEHRS MELISSA KELLY | SVP Alliance and Prog Mgmt | 2013-01-17 | Sale | 28,292.0 | $1.65 |
| Kelsey Stephen Michael | EVP, R&D Head, CMO | 2012-05-30 | Sale | 9,300.0 | $1.37 |
| EARP DAVID | SVP, Corp Transactions | 2012-05-30 | Sale | 27,155.0 | $1.37 |
| Bloom Olivia Kyusuk | VP, Chief Acctg Officer | 2012-05-30 | Sale | 11,029.0 | $1.37 |
| BEHRS MELISSA KELLY | SVP Strategic Portfolio Mgmt | 2012-05-30 | Sale | 18,910.0 | $1.37 |
| SCARLETT JOHN A | President and CEO | 2012-01-24 | Purchase | 75,000.0 | $1.72 |
| KILEY THOMAS | Director | 2011-11-22 | Purchase | 64,275.0 | $1.56 |
| KILEY THOMAS | Director | 2011-10-05 | Purchase | 50,000.0 | $2.03 |
| Spink Katharine E. | SVP Alliance Mgmt & Operations | 2011-06-14 | Sale | 22,591.0 | $4.28 |
| LEBKOWSKI JANE | SVP, Chief Scientific Officer | 2011-06-14 | Sale | 25,262.0 | $4.28 |
| Kelsey Stephen Michael | EVP, R&D Head, CMO | 2011-06-14 | Sale | 4,858.0 | $4.28 |
| BEHRS MELISSA KELLY | SVP Strategic Portfolio Mgmt | 2011-06-14 | Sale | 25,262.0 | $4.28 |
| GREENWOOD DAVID | President, Interim CEO, CFO | 2011-06-14 | Sale | 34,005.0 | $4.28 |
| EARP DAVID | Chief Legal Counsel | 2011-06-14 | Sale | 25,262.0 | $4.28 |
| Bloom Olivia Kyusuk | VP, Chief Acctg Officer | 2011-06-14 | Sale | 6,997.0 | $4.28 |
| Bloom Olivia Kyusuk | VP, Chief Acctg Officer | 2011-05-24 | Sale | 1,200.0 | $4.47 |
| Spink Katharine E. | SVP Prgm Mgmt, Cell Therapies | 2011-05-24 | Sale | 419.0 | $4.47 |
| BEHRS MELISSA KELLY | SVP Strategic Portfolio Mgmt | 2011-05-24 | Sale | 2,975.0 | $4.47 |
| EARP DAVID | SVP Bus Dev, Chief Patnt Couns | 2011-05-24 | Sale | 2,975.0 | $4.47 |
| LEBKOWSKI JANE | SVP, Chief Scientific Officer | 2011-05-24 | Sale | 2,975.0 | $4.47 |
| GREENWOOD DAVID | President, Interim CEO, CFO | 2011-05-24 | Sale | 4,462.0 | $4.47 |
| Kelsey Stephen Michael | EVP, CMO, Oncology | 2011-05-05 | Sale | 14,163.0 | $4.83 |
| Spink Katharine E. | VP Operations, Regen Med Progs | 2010-06-02 | Sale | 8,186.0 | $5.43 |
| LEBKOWSKI JANE | SVP, CSO Regen Med | 2010-06-02 | Sale | 10,617.0 | $5.43 |
| BEHRS MELISSA KELLY | SVP Oncology | 2010-06-02 | Sale | 10,617.0 | $5.43 |
| EARP DAVID | SVP Bus Dev, Chief Patnt Couns | 2010-06-02 | Sale | 10,617.0 | $5.43 |
| GREENWOOD DAVID | EVP and CFO | 2010-06-02 | Sale | 14,746.0 | $5.43 |
| OKARMA THOMAS | President and CEO | 2010-06-02 | Sale | 18,874.0 | $5.43 |
| Spink Katharine E. | VP Operations, Regen Med Progs | 2010-05-24 | Sale | 385.0 | $5.11 |
| LEBKOWSKI JANE | SVP, CSO Regen Med | 2010-05-24 | Sale | 2,336.0 | $5.11 |
| BEHRS MELISSA KELLY | SVP Oncology | 2010-05-24 | Sale | 2,336.0 | $5.11 |
| EARP DAVID | SVP Bus Dev, Chief Patnt Couns | 2010-05-24 | Sale | 2,336.0 | $5.11 |
| GREENWOOD DAVID | EVP and CFO | 2010-05-24 | Sale | 3,503.0 | $5.11 |
| OKARMA THOMAS | President and CEO | 2010-05-24 | Sale | 4,671.0 | $5.11 |
| Kelsey Stephen Michael | EVP, CMO, Oncology | 2010-04-28 | Sale | 3,707.0 | $5.66 |
| Spink Katharine E. | VP Operations, Regen Med Progs | 2009-05-29 | Sale | 400.0 | $6.35 |
| OKARMA THOMAS | President and CEO | 2009-05-29 | Sale | 5,828.0 | $6.35 |
| LEBKOWSKI JANE | SVP, CSO Regen Med | 2009-05-29 | Sale | 2,277.0 | $6.35 |
| BEHRS MELISSA KELLY | SVP Oncology | 2009-05-29 | Sale | 2,277.0 | $6.35 |
| HARLEY CALVIN | VP, CSO Telomerase Tech | 2009-05-29 | Sale | 2,277.0 | $6.35 |
| EARP DAVID | SVP Bus Dev, Chief Patnt Couns | 2009-05-29 | Sale | 2,277.0 | $6.35 |
| GREENWOOD DAVID | EVP and CFO | 2009-05-29 | Sale | 3,416.0 | $6.35 |
| Benedetti Fabio M | SVP, Chief Med Off, Oncology | 2009-05-29 | Sale | 2,277.0 | $6.35 |
| Spink Katharine E. | VP Operations, Regen Med Progs | 2009-05-26 | Sale | 2,864.0 | $6.75 |
| OKARMA THOMAS | President and CEO | 2009-05-26 | Sale | 46,669.0 | $6.75 |
| BEHRS MELISSA KELLY | SVP Oncology | 2009-05-26 | Sale | 6,819.0 | $6.75 |
| LEBKOWSKI JANE | SVP, CSO Regen Med | 2009-05-26 | Sale | 14,092.0 | $6.75 |
| HARLEY CALVIN | VP, CSO Telomerase Tech | 2009-05-26 | Sale | 10,001.0 | $6.75 |
| GREENWOOD DAVID | EVP and CFO | 2009-05-26 | Sale | 19,320.0 | $6.75 |
| EARP DAVID | SVP Bus Dev, Chief Patnt Couns | 2009-05-26 | Sale | 15,456.0 | $6.75 |
| Benedetti Fabio M | SVP, Chief Med Off, Oncology | 2009-04-03 | Sale | 5,195.0 | $4.44 |
| BEHRS MELISSA KELLY | SVP Oncology | 2009-02-02 | Sale | 14,765.0 | $8.12 |
| WALKER JOHN PETER | Director | 2009-01-30 | Sale | 48,617.0 | $8.28 |
| HARLEY CALVIN | VP and CSO | 2009-01-29 | Sale | 25,000.0 | $7.08 |